Moffitt Cancer Center
Detect-Ion, Moffitt Cancer Center Partner on Breath-Based Lung Cancer Test Development
Florida-based Detect-Ion said that the pilot project will use its Clarion mass spectrometry platform for the detection of volatile organic compounds as biomarkers.
Biden Cancer Moonshot Announces New Projects Focused on Decreasing Cancer Burden in Africa
Programs aim to improve screening tools and adherence, advance new point-of-care diagnostics, and increase access to precision medicine on the continent.
Foundation Medicine Monitoring Assays Show Promise for Guiding Lung Cancer Chemo-Immunotherapy
Premium
Investigators showed that patients who are positive for ctDNA at the time of their fourth induction treatment have poorer outcomes and could benefit from new strategies.
Investigators compared expression in different men across the genes from three commercial panels, arguing that the findings highlight important unknowns.
New Coalition, Stakeholder Groups Push Back Against FDA 'Backdoor' Attempts to Regulate PGx Tests
Premium
While some groups have communicated their concerns directly to the agency, stakeholders have also formed a new coalition to publicly take issue with FDA's actions.